# Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
Canonical URL: https://biopharmsignal.com/news/XGN/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026
Ticker: XGN
Company: Exagen
Source: Exagen
Published: 2026-04-27 13:00 EST
Original Source URL: https://investors.exagen.com
## Summary

CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive

## Article Body
CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive
## Recent Company News
- 2026-06-01 13:00 EST — [Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus](https://biopharmsignal.com/news/XGN/exagen-announces-publication-of-systematic-review-confirming-robust-real-world-performance-of-avise-lupus) — Source: Exagen
- 2026-05-11 12:00 EST — [Exagen Inc. Reports First Quarter 2026 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-first-quarter-2026-results) — Source: Exagen
- 2026-04-27 13:00 EST — [Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026](https://biopharmsignal.com/news/XGN/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026) — Source: Exagen
- 2026-03-10 12:00 EST — [Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-strong-fourth-quarter-and-full-year-2025-results) — Source: Exagen
- 2026-03-03 14:00 EST — [Exagen Inc. to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/XGN/exagen-inc-to-participate-in-upcoming-investor-conferences) — Source: Exagen
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)